News
(Alliance News) - Rolls-Royce Holdings PLC on Thursday backed its full-year outlook as it reported a good start to 2025 despite the uncertainties associated with US trade tariffs.
The FTSE 100 was up 0.1% at 8,502.10 in morning trade, inching past the 8,500 mark for the first time in four weeks. The last time the index traded at this level was on 2 April - the day Donald Trump ...
Here is what you need to know at the London market open: FTSE 100: called up 58.7 points, 0.7%, at 8,553.55 Nikkei 225: up 1.0% at 36,420.91 S&P/ASX 200: up 0.2% at 8,145.60 DJIA: closed up 141.74 ...
(Alliance News) - Voters in England will go to the polls on Thursday as Labour faces its first electoral test since taking power last year.
The following is a round-up of earnings for London-listed companies, issued on Wednesday and not separately reported by Alliance News: Ceiba Investments Ltd - investment firm dedicated to investing in ...
(Alliance News) - Playtech PLC on Wednesday said it has completed the sale of Snaitech Spa to Flutter Entertainment PLC for EUR2.30 billion. Isle of Man-based gambling software developer Playtech said ...
(Alliance News) - Hill & Smith PLC on Wednesday said it has poached the chief financial officer of building products peer Ibstock PLC to be its own new CFO. Hill & Smith, a West Midlands, ...
Against that backdrop, as of 0924 GMT, the FTSE 100 was edging up by 0.06% to 8,468.74, alongside a 0.43% gain for the second-tier index to 19,897.79. In parallel, S&P 500 mini futures were little ...
The London-based, Asia-focused insurer said new business profit on a traditional embedded value basis rose 12% to USD608 million in the first quarter of 2025 from USD543 million a year prior at ...
(Alliance News) - Bunzl PLC on Wednesday said it has agreed to buy a healthcare distribution business in Chile, while completing the acquisition of a packaging business in the Netherlands. The ...
GENinCode PLC, down 38% at 1.45p, 12-month range 1.45p-9.625p. The Oxford, England-based genomic testing company focused on the prevention of cardiovascular disease updates on its US Food & Drug ...
Smith & Nephew said headwinds from China "remain an offsetting factor" but it believes it has passed their peak impact. The company left its 2025 guidance unchanged, with expected revenue growth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results